WHO, WIPO, WTO Workshop on Innovation in, and Access to, COVID-19 Technologies - Accessing and Using Information Resources for the Pandemic Response

A virtual workshop jointly organized by the secretariats of the WTO, the World Intellectual Property Organization (WIPO) and the World Health Organization (WHO) on February 28, 2022 will provide an overview of select COVID-19-related information resources.

The workshop aims to enhance understanding of the characteristics, potential uses and limitations of select information sources. A range of experts will discuss information resources containing the following types of data: epidemiological and other health-related issues; clinical trials; technological developments; intellectual property rights; and manufacturing and distribution of and access to technologies, as well as vaccination, diagnostics and treatment rates and cross-border flows of technology.

The workshop responds to the needs of, and is targeted at, policymakers and other stakeholders working on health, intellectual property and trade issues related to the pandemic. The workshop will be held in English only.

Registration for the workshop is mandatory.

The workshop is part of the existing collaboration framework between the three organizations, as highlighted by their Directors-General on 15 June. The aim of these workshops is to strengthen the capacity of policymakers and experts in members of the three organizations to address the pandemic accordingly. The first workshop on Innovation in, and Access to, COVID-19 Technologies was held on 27 September 2021.

Meeting codeWHO-WIPO-WTO/GC/COVID-19/22
Date and venueFebruary 28, 2022 Virtual
Related linksNews: English
WTO Inventory of COVID-19 information resources: English | Français | Español
Topic(s)Workshops and Seminars, COVID-19 meetings and webinars

Meeting documents

CodeTitle(s)File(s)
WHO-WIPO-WTO/GC/COVID-19/22/1EnglishProgramProgram, Complete document (pdf)

Other related documents

Title(s)File(s)
WHO-WIPO-WTO/GC/COVID-19/22/P1EnglishPanel 1: WHO, Ms. Taghreed AdamPanel 1: WHO, Ms. Taghreed Adam, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P2EnglishPanel 1: WHO, Ms. Erika Dueñas LoayzaPanel 1: WHO, Ms. Erika Dueñas Loayza, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P3EnglishPanel 1: WIPO, Ms. Amy Dietterich, Mr. Christophe Mazenc and Mr. Georges GhandourPanel 1: WIPO, Ms. Amy Dietterich, Mr. Christophe Mazenc and Mr. Georges Ghandour, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P4EnglishPanel 2: UNICEF, Ms. Paulina Rivas CalderónPanel 2: UNICEF, Ms. Paulina Rivas Calderón, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P5EnglishPanel 2: World Bank Group, Ms. Priya BasPanel 2: World Bank Group, Ms. Priya Bas, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P6EnglishPanel 2: FIND, The global Alliance for Diagnostics, Mr. Stefano OngarelloPanel 2: FIND, The global Alliance for Diagnostics, Mr. Stefano Ongarello, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P7EnglishPanel 2: Graduate Institute/Global Health Centre Knowledge Portal, Mr. Adrian Alonso RuizPanel 2: Graduate Institute/Global Health Centre Knowledge Portal, Mr. Adrian Alonso Ruiz, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P8EnglishPanel 2: National Institutes of Health ClinicalTrials.gov, Ms. Stacey ArnoldPanel 2: National Institutes of Health ClinicalTrials.gov, Ms. Stacey Arnold, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/P9EnglishPanel 2: Global Healthcare Innovation Alliance Accelerator, Ms. Julia Barnes-WeisePanel 2: Global Healthcare Innovation Alliance Accelerator, Ms. Julia Barnes-Weise, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S1EnglishWTO, Mr. Antony TaubmanWTO, Mr. Antony Taubman, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S2EnglishPanel 1: WTO, Mr. Robert KoopmanPanel 1: WTO, Mr. Robert Koopman, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S3EnglishPanel 1: WHO, Ms. Taghreed AdamPanel 1: WHO, Ms. Taghreed Adam, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S4EnglishPanel 1: WHO, Ms. Erika Dueñas LoayzaPanel 1: WHO, Ms. Erika Dueñas Loayza, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S5EnglishPanel 1: WIPO, Ms. Amy DietterichPanel 1: WIPO, Ms. Amy Dietterich, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S6EnglishPanel 1: WIPO, Mr. Christophe MazencPanel 1: WIPO, Mr. Christophe Mazenc, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S7EnglishPanel 1: WIPO, Mr. Georges GhandourPanel 1: WIPO, Mr. Georges Ghandour, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S8EnglishPanel 2: UNICEF, Ms. Paulina Rivas CalderónPanel 2: UNICEF, Ms. Paulina Rivas Calderón, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S9EnglishPanel 2: World Bank Group, Ms. Priya BasuPanel 2: World Bank Group, Ms. Priya Basu, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S10EnglishPanel 2: FIND, Mr. Stefano OngarelloPanel 2: FIND, Mr. Stefano Ongarello, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S11EnglishPanel 2: Graduate Institute, Mr. Adrian Alonso RuizPanel 2: Graduate Institute, Mr. Adrian Alonso Ruiz, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S12EnglishPanel 2: NIH, Ms. Stacey ArnoldPanel 2: NIH, Ms. Stacey Arnold, Complete document (pdf)
WHO-WIPO-WTO/GC/COVID-19/22/S13EnglishPanel 2: GHIAA, Ms. Julia Barnes-WeisePanel 2: GHIAA, Ms. Julia Barnes-Weise, Complete document (pdf)